๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

BIOSIMILAR DRUG PRODUCT DEVELOPMENT

โœ Scribed by Laszlo Endrenyi, Dr. Paul Declerck, Shein-Chung Chow


Publisher
CRC Press
Year
2017
Tongue
English
Leaves
496
Series
Drugs and the Pharmaceutical Sciences
Edition
1
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Synopsis


When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.

โœฆ Table of Contents


Content: Analytical characterization. Immunogenicity. Animal studies. Clinical development. Manufacturing, process control. Extrapolation of indications. Interchangeability, substitution. Pharmacovigilance. Statistical issues. Regulatory issues.


๐Ÿ“œ SIMILAR VOLUMES


Biosimilar Drug Product Development
โœ Laszlo Endrenyi, Dr. Paul Declerck, Shein-Chung Chow ๐Ÿ“‚ Library ๐Ÿ“… 2017 ๐Ÿ› CRC Press ๐ŸŒ English

<P>When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. <B><EM>Biosimilar D

Methodologies in Biosimilar Product Deve
โœ Sang Joon Lee, Shein-Chung Chow ๐Ÿ“‚ Library ๐Ÿ“… 2021 ๐Ÿ› CRC Press/Chapman & Hall ๐ŸŒ English

<p><span>Methodologies for Biosimilar Product Development</span><span> covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar product. These practical and challenging issues include, but are not limited to the m

Introduction to Biologic and Biosimilar
โœ Karen M. Nagel ๐Ÿ“‚ Library ๐Ÿ“… 2018 ๐Ÿ› Springer International Publishing ๐ŸŒ English

<p>The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduct

Biosimilars: Regulatory, Clinical, and B
โœ Hiten J. Gutka, Harry Yang, Shefali Kakar ๐Ÿ“‚ Library ๐Ÿ“… 2018 ๐Ÿ› Springer International Publishing ๐ŸŒ English

<p><p>This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the